Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-20-019201
Date:2020-07-13
Issuer: CORCEPT THERAPEUTICS INC (CORT)
Original Submission Date:

Reporting Person:

HUNT HAZEL
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE MENLO PARK, CA 94025

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 15.82 2020-07-13 deemed execution date A 40,000 (a) 2030-07-13 common stock 40,000 $15.82 40,000 direct
Footnotes
IDfootnote
f1 shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of july 1, 2020, so that the total number of shares subject to this option becomes fully vested and exercisable on july 1, 2024.
WhaleWisdom Logo

Elevate your investments